ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 179187 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 179187; 2) Community: the network communities that were significantly associated with the response to NSC 179187; 3) Molecule: the relationships between components within communities and NSC 179187; 4) MDR: the compounds that were significantly associated with the NSC 179187.

NSC Compound Enrichment Correlation
NSC 107043 Null 0.0430505868034761 -0.15170471
NSC 133118 2H-1,2,3-Triazolo[4,5-d]pyrimidin-7-amine, 2-.beta.-D-ribofuranosyl- (9CI) 0.0430505868034761 -0.028711171
NSC 135962 Aracytidine 5'-palmitate 0.0430505868034761 0.07566398
NSC 176323 Camptothecin Derivative 0.0430505868034761 0.13015154
NSC 21683 Null 0.0430505868034764 -0.011525208
NSC 292816 1-Butanone, 1,1'-(9-ethyl-9H-carbazole-3,6-diyl)bis[4-(dimethylamino)-, (E)-2-butenedioate (1:1) 0.0430505868034764 0.19995931
NSC 295499 Camptothecin Derivative 0.0430505868034764 0.20483138
NSC 319947 2,4-Pyrimidinediamine, 5-(3-azido-4-chlorophenyl)-6-ethyl- 0.0430505868034764 -0.1150321
NSC 335753 HELIANGOLIDE 0.0430505868034764 -0.11122134
NSC 354051 LISCUNDITRIN 0.0430505868034764 -0.057090901
Total:43  Current:36    [First] [Prev] [Next] [Last]